Dayer Jm
Impact in
- Rheumatology top 10%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
-
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
-
- Systemic Sclerosis and Related Diseases 4
-
- Rheumatoid Arthritis Research and Therapies 3
- Systemic Lupus Erythematosus Research 2
- Co-authors
- P Roux‐Lombard (2 shared papers)T. L. Vischer (2 shared papers)Stephen Demczuk (2 shared papers)Cem Gabay (1 shared paper)Van Damme J (1 shared paper)Prieur Am (1 shared paper)Bernard Mach (1 shared paper)Christophe Baumberger (1 shared paper)
- Journals
- PubMed (21 papers)
- Partner nations
- SwitzerlandFrancePoland
In The Last Decade
Dayer Jm
20 papers receiving 330 citations
Peers
Comparison fields: 5 of 71
- Rheumatology 96
- Immunology 137
- Hematology 38
- Immunology and Allergy 15
- Behavioral Neuroscience 8
Countries citing papers authored by Dayer Jm
This map shows the geographic impact of Dayer Jm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dayer Jm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dayer Jm more than expected).
Fields of papers citing papers by Dayer Jm
This network shows the impact of papers produced by Dayer Jm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dayer Jm. The network helps show where Dayer Jm may publish in the future.
Co-authors
The 25 scholars most cited alongside Dayer Jm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. | 1993 | 70 |
| 2 | Limited effects of recombinant human and murine interleukin 1 and tumour necrosis factor on production of acute phase proteins by cultured rat hepatocytes. | 1987 | 46 |
| 3 | Normal epidermis contains high amounts of natural tissue IL 1 biochemical analysis by HPLC identifies a MW approximately 17 Kd form with a P1 5.7 and a MW approximately 30 Kd form. | 1986 | 38 |
| 4 | Expression of human IL 1 alpha and beta messenger RNAs and IL 1 activity in human peripheral blood mononuclear cells. | 1987 | 32 |
| 5 | Dynamics of fever and the cytokine network in systemic juvenile arthritis. | 1996 | 31 |
| 6 | Modulation of IL-1 inflammatory and immunomodulatory properties by IL-6. | 1991 | 29 |
| 7 | Inhibitors of interleukin 1 activity in synovial fluids and in cultured synovial fluid mononuclear cells. | 1992 | 24 |
| 8 | Collagens stimulate the production of mononuclear cell factor (MCF) and prostaglandins (PGE2) by human monocytes. | 1980 | 15 |
| 9 | Collagenase and prostaglandin in connective tissue destruction: cell-cell and humoral interactions. | 1979 | 9 |
| 10 | Phagocytosis, bactericidal capacity, and PGE2 production of monocytes in systemic lupus erythematosus and rheumatoid arthritis. | 1984 | 9 |
| 11 | Cell-cell interactions and tissue damage in rheumatoid arthritis. | 2004 | 9 |
| 12 | Human circulating monocytes internalize 125I-insulin in a similar fashion to rat hepatocytes: relevance to receptor regulation in target and nontarget tissues. | 1985 | 8 |
| 13 | Production of mononuclear cell factor by mononuclear phagocytes from rheumatoid synovial fluid. | 1985 | 8 |
| 14 | Natural inhibitors of TNF. | 1992 | 7 |
| 15 | [Effect of neurotransmitters and psychotropic drugs on the immune system. Mediator role of hormones and clinical implications]. | 1982 | 4 |
| 16 | Production of prostaglandin E2 and collagenase is inhibited by the recombinant soluble tumour necrosis factor receptor p55-human gamma 3 fusion protein at concentrations a hundred-fold lower than those decreasing T cell activation. | 1996 | 4 |
| 17 | [Cytokines and anti-cytokines in inflammatory rheumatism]. | 1994 | 3 |
| 18 | [Biological modulation of IL-1 activity: role and development of its natural inhibitor IL-1Ra]. | 2004 | 2 |
| 19 | [Polyvinyl alcohol as suture material: results after 1 year]. | 1969 | 2 |
| 20 | [Scleroderma, renal failure, accelerated hypertension and microangiopathic hemolytic anemia]. | 1974 | 1 |
About Dayer Jm
Dayer Jm is a scholar working on Pathology and Forensic Medicine, Rheumatology, Oncology, Immunology and Molecular Biology, having authored 21 papers that have together received 352 indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (4 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Cell Adhesion Molecules Research (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Immune Response and Inflammation (3 papers), Systemic Lupus Erythematosus Research (2 papers), Protein purification and stability (1 paper) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper). The work is most often cited by research in Rheumatology (96 citations), Immunology (137 citations), Hematology (38 citations), Immunology and Allergy (15 citations) and Behavioral Neuroscience (8 citations). Dayer Jm has collaborated with scholars based in Switzerland, France and Poland. Frequent co-authors include P Roux‐Lombard, T. L. Vischer, Stephen Demczuk, Cem Gabay, Van Damme J, Prieur Am, Bernard Mach, Christophe Baumberger, Carl J. Hauser and Anita Schmitt. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.